Brief: Coherus BioSciences Q1 EPS USD 0.83
09/05/2024 21:01
May 09 (Reuters) - Coherus BioSciences Q1 operating income USD -42.525 million. * Q1 pretax profit USD 102.875 million vs. IBES estimate USD -25.5 million * Q1 net income USD 102.875 million * Q1 sales USD 77.063 million vs. IBES estimate USD 80.2 million * Q1 adjusted net income USD -35.751 million vs. IBES estimate USD -25.7 million
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million